Clinical Trial Update: Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing ovarian reserve after using Floseal Matrix for ovarian hemostasis in ovarian cyst surgery; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cysts

Drugs mentioned

• Floseal Matrix (gelatin-thrombin matrix hemostatic agent)

Snippet

Sponsor: CHA University | Conditions: Ovarian Cysts | Phase 3 | Status: COMPLETED